Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Motor Activity 3Lung Neoplasms 2Esophageal Neoplasms 2Stomach Neoplasms 1Pediatric Brain Tumor 1Insulin Resistance 1Hodgkin Disease 1Gastrointestinal Neoplasms 1Disease 1Brain Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 49Carboplatin 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Pemetrexed 35Cisplatin 26Blood Specimen Collection 25durvalumab 17Paclitaxel 17osimertinib 15Radiosurgery 15Bevacizumab 15Radiotherapy 14Nivolumab 14Gemcitabine 14atezolizumab 13Biopsy 13Drug Therapy 12Docetaxel 11130-nm albumin-bound paclitaxel 11Immunoglobulin G 10X-Rays 9Taxes 9Standard of Care 9Practice Guidelines as Topic 9Educational Status 9Disulfides 9tislelizumab 8Etoposide 8Cetuximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Lung Neoplasms × High-Intensity Interval Training × Clear all
NCT06026111 2026-04-14

ENHANCE

Dana-Farber Cancer Institute

Phase NA Recruiting
30 enrolled
Thoracic

Lung Neoplasms

NCT06215326 2024-03-01

PRE-EXELUCA

Guangdong Provincial People's Hospital

Phase NA Recruiting
100 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡